Kymera Investor Day Presentation Deck slide image

Kymera Investor Day Presentation Deck

Safety, PK and PD from SAD and MAD Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers Jared Gollob, M.D., Chief Medical Officer, Kymera KYMERA KYMERA R&D DAY - December 16th, 2021 5 KYMERA EST. 2016
View entire presentation